Megha Aggarwal

4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication

Julien Sourimant, Carolin M. Lieber, Megha Aggarwal et al. · Science · 2022 · 118 citations · Full text

Oral Antiviral, Respiratory Virus Immunity, Viral Polymerase Structure +17

Structure of a paramyxovirus polymerase complex reveals a unique methyltransferase-CTD conformation

R. Abdella, Megha Aggarwal, Takashi Okura et al. · Proceedings of the National Academy of Sciences · 2020 · 110 citations · Full text

Evaluation of antiviral activity of piperazine against Chikungunya virus targeting hydrophobic pocket of alphavirus capsid protein

Megha Aggarwal, Ramanjit Kaur, Amrita Saha et al. · Antiviral Research · 2017 · 67 citations

Alphavirus Capsid Protein, Neurovirology, Antiviral Activity +9

4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.

Julien Sourimant, Carolin M. Lieber, Megha Aggarwal et al. · PubMed · 2022 · 57 citations · Full text

Kinetic characterization of trans-proteolytic activity of Chikungunya virus capsid protease and development of a FRET-based HTS assay

Megha Aggarwal, Rajesh Sharma, Pravindra Kumar et al. · Scientific Reports · 2015 · 50 citations · Full text